Smell China

China will next year, July 1 implementation of the new “Chinese Pharmacopoeia.” It is said to further strengthen the Chinese Pharmacopoeia for drug supervision and management to provide a strong support.

“Chinese Pharmacopoeia” is the state to ensure drug quality control, ensuring drug safety and effectiveness of the people by law to develop drugs code, is a pharmaceutical research and development, production, operation, use and management must be in strict compliance with statutory basis. It is understood that there are three new Pharmacopoeia, namely medicine, chemical drugs and biological products, received a total of more than 4600 kinds of varieties containing drugs.

China’s State Food and Drug Administration spokesman Yan Miss Jiang Ying said that China has been compiled over the previous version 8 pharmacopoeia. Compared with the past, the new Pharmacopoeia substantially increases the security of test items, and further strengthen the heavy metals or harmful elements, impurities, residual solvent control; other varieties of traditional Chinese medicine containing relevant substantial increase in the number of traditional Chinese medicine and related resource protection of Standards and Technology further improved.